Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Tuesday, November 29, 2022 · 603,744,663 Articles · 3+ Million Readers

Global Generic Oncology Drugs Market Size to Hit USD 27,815 million by 2025: ZMR Statistics Report

Global Generic Oncology Drugs Market

Global Generic Oncology Drugs Market

The global generic oncology drugs market was $18,190 mn in 2018 and is expected to generate around $27,815 mn by 2025, at a CAGR of 6.3% between 2019 and 2025.

Global Generic Oncology Drugs Market 2022 Demand Analysis, Industry Size, Share Estimation, Top Leading Companies, Revenue and Forecast to 2028”
— Zion Market Research

SARASOTA, FLORIDA, UNITED STATES, September 30, 2022 / -- Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”.

According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021.

Pharmacology is the study of drugs and medicines, including their uses, effects, and characteristic. Generic drugs are chemically identical to their branded counterparts. Although generic drugs are bioequivalent to branded drugs, they are sold at the significant discount from branded drugs prices.

As per the FDA approval, the generic drug should contain the same active ingredient as their branded counterpart; it should be bioequivalent and should meet batch requirements for identity, quality, purity, and strength.

It should be identical on the route of administration and dosage form. It should be manufactured under the same rules and regulation of FDA’s good manufacturing practice required for branded drugs.

Generic drugs manufacturing companies are capable of selling generic drugs at the lower price because they are not required to repeat costly clinical trials and pay for marketing and promotion strategies.

Request a Free Sample copy of the Generic Drug Market Report @

Browse through 13 Market Tables and 24 Figures spread through 110 Pages and in-depth TOC on “Global Generic Drug Market: By Brands, Application, Size, Share, Trends, Manufacturers, Segment and Forecast 2015-2021”.

Globally, the market for the generic drug has been propelled by new government initiatives to produce generic drugs and mainly to promote the use of generic drugs against chronic diseases. Patent expiration of branded drugs is one of the key influencers for the growth and prime reason for generating more revenue for generic drugs market.

Moreover, new emerging markets of developing countries and low cost of generic drugs are majorly responsible for thickening the growth of generic drugs market. In spite of this, the market is affected by high competition within the globe and it is due to, economic expenditure required for the production of generic drugs is the very low thus a number of leading companies taking interest in the production of generic drugs. In future, new developing and uncovered markets may responsible for the generation of new opportunities.

The the market for the generic drug has been segmented on the basis of the brand as pure generic drug and branded generic drugs. Branded generic drugs are marketed under another company’s brand name but they are bioequivalent to their generic counterparts. Due to high involvement of companies in manufacturing pure generic drugs, pure generic drug segment is dominating the market.

Based on the therapeutic application the market of generic drugs has been segmented as central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. With more than 20% revenue contribution, the cardiovascular segment was leading the generic drug market in 2015 due to a number of patent expiry of cardiovascular drugs. With more than 15 % revenue contribution, central nervous system (CNS) will show significant growth over the forecast period.

North America held largest market share in the generic drug market in 2015. In the U.S. more than 88% prescriptions patterns are filled by generic drugs, thus the demand is high for the genetic drug. In addition, Europe is expected to show significant growth for generic drug market as a result of increasing prevalence of chronic diseases and government support.

Browse Press Release @

In Asia Pacific, India and China dominated the generic drug market in terms of volume. India is leading country in Asia Pacific region due to a number of Indian companies seeking regulatory approvals in the U.S. and other countries. Total Indian genetic market was around USD 21 billion in 2015 and it is mainly due to various Indian companies have got international regulatory approvals like the U.S. FDA, MHRA-UK, TGA-Australia and MCC-South Africa for their manufacturing plant. India is the largest exporter of the generic drug; leading Indian generic companies are generating more than 50% revenue from the export business of generic drug.

In 2015, Brazil was the largest generic market in Latin America and it is due to the sale of generic drugs was accounted 23% of pharmaceutical sector by value and 25% by volume. It is expected to remain dominant in Latin America in forecast period due to high demand and increasing development in the pharmaceutical sector.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

-Teva Pharmaceutical Industries Ltd.
-Novartis International AG
-Mylan N.V.
-Abbott Healthcare Pvt. Ltd.
-Actavis Pharmaceuticals
-Sun Pharmaceuticals.

Purchase a direct copy of report with TOC @

This report segments the generic drugs market as follows:

Generic Drugs Market: Brand Segment Analysis

Pure generic drugs
Branded generic drugs

Generic Drugs Market: Therapeutic Application Segment Analysis

Central nervous system (CNS)

Generic Drugs Market: Regional Segment Analysis

North America
Asia Pacific
Latin America
The Middle East and Africa

Pharmaceutical Research Reports -


1) What was the value of the global Generic Oncology Drugs Market in 2020?
2) What will be the size of the global Generic Oncology Drugs Market in 2028?
3) What are the key factors driving the global Generic Oncology Drugs Market growth?
4) Which region will make notable contributions to the global Generic Oncology Drugs Market?
5) Who are the major companies operating in the global Generic Oncology Drugs Market?

What’s included In the Report?

-Top Market Players with Sales, Revenue, and Business Strategies Analysis
-Market Growth Drivers and Restraints
-Market Opportunities & Challenges
-Research Methodology
-Analysis of the market of various perspectives

Read Our Related Report @

Related Reports:

Hemophilia Treatment Market:
Empty Capsules Market:
Intravenous Immunoglobulin Market:
Allergy Immunotherapy Market:
Peptide and Anticoagulant Drugs Market:
Cellulite Treatment Market:

Kavita More
Zion Market Research
+1 855-465-4651
Visit us on social media:

Global Behavioral Health Market Size & Share Will Reach USD 4748.9 Million by 2025

Powered by EIN Presswire

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release